Assessment of Insulin Therapy Effectiveness in Type 2 Diabetes Patients
This study aims to observe and compare the blood glucose and HbA1C levels in type 2 diabetes patients who are undergoing insulin therapy with those who are using oral antidiabetic medication.
Data Collection
Collected from today forward - ProspectiveDiabetes Mellitus+3
+ Diabetes Mellitus, Type 2
+ Endocrine System Diseases
Cohort
Tracking disease incidence in order to identify risk factors and understand disease progression over time.Summary
Study start date: April 1, 2025
Actual date on which the first participant was enrolled.Diabetes is a health condition where the body either doesn't produce enough insulin or can't effectively use the insulin it does produce. This leads to high levels of sugar, or glucose, in the blood. Type 2 diabetes is the most common form, making up about 90% of all diabetes cases worldwide. This condition is becoming increasingly prevalent, especially in Egypt, which is among the top ten countries with the highest proportion of adults with diabetes. The study focuses on Type 2 diabetes patients in Egypt, aiming to understand and improve their treatment. This observational study compares the effectiveness of insulin therapy and oral anti-diabetic medication in managing Type 2 diabetes. It measures two primary outcomes: blood glucose levels and HbA1C levels. Blood glucose levels are a snapshot of the amount of sugar in the blood at a given time, while HbA1C levels provide an average measure of blood sugar control over a longer period. By comparing these levels in patients using insulin therapy and those using oral medication, the study aims to provide insights into which treatment approach is more effective.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.100 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Cohort
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Conditions
Pathology
Criteria
Inclusion Criteria: -Patients with type 2 diabetes mellitus aged ≥18 years. * Patients going on insulin therapy versus patients going on oral antidiabetic drugs. * patients included if they met the following Criteria: * previous diagnosis of diabetes mellitus or on medical therapy of DM. * no prescription fills for a basal insulin containing product in the 1-year pre index date period; and no prescription fills for bolus insulin or mixed insulin products on index date or in the 1-year pre-index date periods. Exclusion Criteria: * Patients had type 1 diabetes mellitus. * Pregnant patients. * Incapable of completing the study questionnaires. * were pregnant at any time during the pre-or post-index periods; or * were diagnosed with any other type of diabetes during the study period, including, gestational diabetes , secondary diabetes , or other abnormal glu-cose conditions . * Patients who were con-comitantly participating in another trial or receiving insulin treatment for reasons other than T2DM.
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Primary Objectives